Breaking News Instant updates and real-time market news.

OVID

Ovid Therapeutics

$2.10

0.28 (15.38%)

08:09
05/07/19
05/07
08:09
05/07/19
08:09

Ovid Therapeutics reports Q1 EPS (46c), consensus (42c)

As of March 31, cash, cash equivalents, and short-term investments totaled $59.6M.

  • 07

    Jun

OVID Ovid Therapeutics
$2.10

0.28 (15.38%)

11/15/18
CANT
11/15/18
INITIATION
Target $10
CANT
Overweight
Ovid Therapeutics initiated with an Overweight at Cantor Fitzgerald
Cantor Fitzgerald analyst Charles Duncan last night initiated coverage of Ovid Therapeutics with an Overweight rating and $10 price target. The analyst rolled out coverage on five Neuro-Innovator companies, focusing on "innovative technologies that can lead to breakthrough and disruptive treatments." He believes all five companies have "growth potential that exceeds current valuations, over time."
12/17/18
PIPR
12/17/18
NO CHANGE
Target $20
PIPR
Overweight
Ovid shares should be up more on epilepsy data, says Piper Jaffray
After Ovid Therapeutics reported that a correlation was observed between reductions in seizure frequency and decreases in 24HC plasma levels in its Phase Ib/IIa OV935 all-comer trial in adults, Piper Jaffray analyst Tyler Van Buren said he views the data as validating of the OV935 mechanism and argued that the shares should be up more this morning. Ovid shares aren't trading far from cash, reflecting "little-to-no value" for OV935 despite the "encouraging" initial data in epilepsy and OV101, which has a pivotal pathway forward in Angelman's, according to Van Buren. He reiterates an Overweight rating on Ovid shares with a price target of $20.
03/08/19
JMPS
03/08/19
NO CHANGE
Target $11
JMPS
Outperform
Ovid Therapeutics price target lowered to $11 from $26 at JMP Securities
JMP Securities analyst Jason Butler lowered his price target for Ovid Therapeutics to $11 from $26 to reflect equity dilution following last month's equity offering. He maintains an Outperform rating on the stock following the company's quarterly update, noting that the company remains on track to initiate the Phase 3 trial for OV101 in Angelman syndrome in the second half of this year and he anticipates results from the ARCADE trial of OV935 in severe pediatric epilepsies by the end of 2019.
03/10/19
PIPR
03/10/19
NO CHANGE
Target $14
PIPR
Overweight
Ovid Therapeutics price target lowered to $14 from $20 at Piper Jaffray
Piper Jaffray analyst Tyler Van Buren lowered his price target Ovid Therapeutics to $14 after the company reported Q4 results and provided an updated outlook for 2019. The analyst, however, believes Ovid's three programs could result in "significant upside" from current share levels. He keeps an Overweight rating on the shares.

TODAY'S FREE FLY STORIES

LOW

Lowe's

$108.61

-0.39 (-0.36%)

, HD

Home Depot

$192.49

-0.04 (-0.02%)

10:31
05/20/19
05/20
10:31
05/20/19
10:31
On The Fly
Fly Intel: What to watch in Home Depot, Lowe's earnings reports »

Home improvement…

LOW

Lowe's

$108.61

-0.39 (-0.36%)

HD

Home Depot

$192.49

-0.04 (-0.02%)

AMZN

Amazon.com

$1,851.99

-16.33 (-0.87%)

SHLD

Sears

$0.00

(0.00%)

JCP

J.C. Penney

$1.11

-0.035 (-3.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 21

    May

  • 21

    May

  • 22

    May

  • 22

    May

  • 23

    May

  • 24

    May

  • 29

    May

  • 31

    May

  • 03

    Jun

  • 24

    Jun

TSLA

Tesla

$199.00

-12.02 (-5.70%)

, TROW

T. Rowe Price

$103.87

-0.55 (-0.53%)

10:31
05/20/19
05/20
10:31
05/20/19
10:31
On The Fly
Tesla dips below $200 as analysts voice concern over Model 3 demand »

Shares of Tesla (TSLA)…

TSLA

Tesla

$199.00

-12.02 (-5.70%)

TROW

T. Rowe Price

$103.87

-0.55 (-0.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Jun

VRNA

Verona Pharma

$5.90

-0.45 (-7.09%)

10:20
05/20/19
05/20
10:20
05/20/19
10:20
Hot Stocks
Verona Pharma presents expanded analysis of ensifentrine clinical data »

Verona Pharma presented…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYL

Mylan

$19.26

-0.38 (-1.93%)

, TBPH

Theravance Biopharma

$20.19

-0.44 (-2.13%)

10:19
05/20/19
05/20
10:19
05/20/19
10:19
Hot Stocks
Theravance, Mylan study highlights possible role of Yupelri in COPD treatment »

Theravance Biopharma…

MYL

Mylan

$19.26

-0.38 (-1.93%)

TBPH

Theravance Biopharma

$20.19

-0.44 (-2.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

10:19
05/20/19
05/20
10:19
05/20/19
10:19
Conference/Events
Wolfe Research IT hardware analyst to hold an analyst/industry conference call »

IT Hardware &…

GOOS

Canada Goose

$47.69

-0.65 (-1.34%)

, OSW

OneSpaWorld

$13.55

0.05 (0.37%)

10:17
05/20/19
05/20
10:17
05/20/19
10:17
Initiation
Fly Intel: Top five analyst initiations »

Catch up on today's…

GOOS

Canada Goose

$47.69

-0.65 (-1.34%)

OSW

OneSpaWorld

$13.55

0.05 (0.37%)

ZM

Zoom Video

$86.55

-3.36 (-3.74%)

BYND

Beyond Meat

$88.70

-0.63 (-0.71%)

FMC

FMC Corporation

$74.01

-1.24 (-1.65%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 23

    May

  • 06

    Jun

AAL

American Airlines

$30.38

-1.38 (-4.35%)

, DAL

Delta Air Lines

$54.07

-0.82 (-1.49%)

10:17
05/20/19
05/20
10:17
05/20/19
10:17
Downgrade
Fly Intel: Top five analyst downgrades »

Catch up on today's…

AAL

American Airlines

$30.38

-1.38 (-4.35%)

DAL

Delta Air Lines

$54.07

-0.82 (-1.49%)

DB

Deutsche Bank

$7.42

-0.16 (-2.11%)

EV

Eaton Vance

$36.91

-0.895 (-2.37%)

PRA

ProAssurance

$38.42

-0.72 (-1.84%)

CLX

Clorox

$147.09

0.03 (0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 21

    May

  • 22

    May

  • 22

    May

  • 29

    May

  • 03

    Jun

  • 11

    Jun

  • 12

    Jun

  • 12

    Jun

  • 20

    Jun

GD

General Dynamics

$169.82

3.43 (2.06%)

, TGT

Target

$71.62

0.74 (1.04%)

10:17
05/20/19
05/20
10:17
05/20/19
10:17
Upgrade
Fly Intel: Top five analyst upgrades »

Catch up on today's…

GD

General Dynamics

$169.82

3.43 (2.06%)

TGT

Target

$71.62

0.74 (1.04%)

NPTN

NeoPhotonics

$3.99

0.16 (4.18%)

UAL

United Continental

$81.40

-0.12 (-0.15%)

JACK

Jack in the Box

$82.09

-0.13 (-0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 22

    May

  • 22

    May

  • 28

    May

  • 29

    May

  • 04

    Jun

  • 12

    Jun

  • 25

    Jun

  • 27

    Jun

  • 08

    Aug

TRN

Trinity Industries

$20.78

-0.15 (-0.72%)

10:17
05/20/19
05/20
10:17
05/20/19
10:17
Hot Stocks
Trinity Industries announces strategic railcar maintenance network expansion »

Trinity Industries…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jun

  • 13

    Nov

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
05/20/19
05/20
10:17
05/20/19
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
05/20/19
05/20
10:16
05/20/19
10:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:15
05/20/19
05/20
10:15
05/20/19
10:15
Conference/Events
Wolfe Research healthcare analyst to hold analyst/industry conference call »

Healthcare Services…

10:15
05/20/19
05/20
10:15
05/20/19
10:15
General news
Oil Action: WTI crude »

Oil Action: WTI crude…

10:15
05/20/19
05/20
10:15
05/20/19
10:15
General news
Fed's Harker didn't discuss policy or the economy »

Fed's Harker…

10:10
05/20/19
05/20
10:10
05/20/19
10:10
General news
U.S. corporate bond update: several issues are on the docket »

U.S. corporate bond…

FLIC

First Long Island

$22.31

(0.00%)

10:04
05/20/19
05/20
10:04
05/20/19
10:04
Hot Stocks
First Long Island names Janet Verneuille EVP, CRO »

The First of Long Island…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSC

Studio City

$17.00

(0.00%)

10:00
05/20/19
05/20
10:00
05/20/19
10:00
Hot Stocks
Studio City falls -7.3% »

Studio City is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BNED

Barnes & Noble Education

$3.40

-0.26 (-7.10%)

10:00
05/20/19
05/20
10:00
05/20/19
10:00
Hot Stocks
Barnes & Noble Education falls -7.7% »

Barnes & Noble…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KEYS

Keysight Technologies

$73.76

-8.12 (-9.92%)

10:00
05/20/19
05/20
10:00
05/20/19
10:00
Hot Stocks
Keysight Technologies falls -9.8% »

Keysight Technologies is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

SMI

SMIC

$5.39

0.38 (7.58%)

10:00
05/20/19
05/20
10:00
05/20/19
10:00
Hot Stocks
SMIC rises 7.6% »

SMIC is up 7.6%, or 38c…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WBK

Westpac Banking

$18.98

1.63 (9.39%)

10:00
05/20/19
05/20
10:00
05/20/19
10:00
Hot Stocks
Westpac Banking rises 9.2% »

Westpac Banking is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

S

Sprint

$7.64

1.46 (23.64%)

10:00
05/20/19
05/20
10:00
05/20/19
10:00
Hot Stocks
Sprint rises 23.5% »

Sprint is up 23.5%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BSX

Boston Scientific

$36.83

-0.49 (-1.31%)

09:55
05/20/19
05/20
09:55
05/20/19
09:55
Conference/Events
Boston Scientific to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    May

  • 29

    May

  • 26

    Jun

  • 13

    Nov

UNM

Unum Group

$34.79

-0.01 (-0.03%)

09:55
05/20/19
05/20
09:55
05/20/19
09:55
Conference/Events
Unum Group participates in a conference call with JPMorgan »

Life Insurance Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    May

  • 23

    May

  • 11

    Jun

RDY

Dr. Reddy's

$36.93

-2.38 (-6.05%)

09:47
05/20/19
05/20
09:47
05/20/19
09:47
Hot Stocks
Dr. Reddy's falls -6.2% »

Dr. Reddy's is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.